Want to join the conversation?
$CTXS said that its restructuring plans are intended to generate permanent expense reductions allowing the company to execute more efficiently, while also driving scalability into the future. In 2Q16, the company stated that it posted 28% adjusted op margin, up 370 BP from 2Q15 and is well ahead of its stated goal of reaching 30% in FY17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.